NDAORALTABLET
Approved
Aug 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Clinical Trials (4)
Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma
Started Feb 2014
0Urothelial Carcinoma
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Started Oct 2011
24 enrolled
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+13 more
AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)
Started Apr 2011
223 enrolled
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cancer
A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors
Started Jun 2009
18 enrolled
Neoplasms, Advanced Solid